The answer according to this short essay is “yes”. This paper, however, will not resolve the debate about the benefits and risks associated with the early use of ADT when PSA continues to rise after a prostatectomy. Anyone following the literature reviewed here over the past few years knows that the data keep coming in showing both benefits and risks to early use of ADT.
Stone L. 2016. Prostate cancer: ADT after radical prostatectomy - when and how? Nat Rev Urol 13(7):367. www.ncbi.nlm.nih.gov/pubmed/27215428